Magnetic bead technology in viral RNA and DNA extraction from plasma minipools

被引:22
作者
Pichl, L
Heitmann, A
Herzog, P
Oster, J
Smets, H
Schottstedt, V
机构
[1] German Red Cross Blood Transfus Serv W, Cent Lab, D-58097 Hagen, Germany
[2] Artus GmbH, Hamburg, Germany
[3] Chemagen AG, Baesweiler, Germany
关键词
D O I
10.1111/j.1537-2995.2005.04356.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Nucleic acid testing (NAT) of pooled plasma samples from individual blood donations for viral nucleic acids has become widely established. Full automation of such sample processing can overcome many of the problems associated with methods used so far. STUDY DESIGN AND METHODS: In this study an automated extraction method for viral nucleic acids (parvovirus [PAV] B19 DNA, hepatitis B virus [HBV] DNA, and hepatitis A virus [HAV] RNA), starting directly from the minipool sample (n = 96, 9.6 mL), was evaluated. A magnetic separation module I (chemagic, Polymer Laboratories) in combination with the chemagic viral DNA and RNA kit special based on the use of magnetic beads was used for this purpose. More than 144 pools spiked with defined concentrations of reference material and an additional 102 pools negative for the analyte were extracted and amplified. The isolated viral nucleic acids were detected by polymerase chain reaction (PCR). RESULTS: The assays were highly specific and obtained a 95 percent detection limit of 875 IU per mL of pooled single donation for PAV B19, 260 IU per mL for HAV, and 1274 IU per mL for HBV, respectively. The crossing points showed variation coefficients from 1.49 to 2.76 percent. The turnaround time for the whole process was 3 hours. Testing of subpools to determine an infected single donation would be possible with the same general extraction method. A total of 102 unspiked minipools (96 x 100 p L per donation) were analyzed and none tested positive. CONCLUSION: The automated magnetic bead-based extraction in combination with real-time PCR detection can be used to routinely screen blood donations for viremic donors to further increase the safety of blood products. Minipools as well as subpools can be directly processed.
引用
收藏
页码:1106 / 1110
页数:5
相关论文
共 9 条
[1]  
Fenner T., 2000, Vox Sanguinis, V78, pP438
[2]   The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations [J].
Jackson, BR ;
Busch, MP ;
Stramer, SL ;
AuBuchon, JP .
TRANSFUSION, 2003, 43 (06) :721-729
[3]   Automation of nucleic acid extraction for NAT screening of individual blood units [J].
Lee, DH ;
Prince, AM .
TRANSFUSION, 2001, 41 (04) :483-487
[4]   Recent developments in laboratory automation using magnetic particles for genome analysis [J].
Obata, K ;
Tajima, H ;
Yohda, M ;
Matsunaga, T .
PHARMACOGENOMICS, 2002, 3 (05) :697-708
[5]  
PICHL L, 2001, TRANSFUS CLIN BIO S1, V8, pP135
[6]   The german experience with NAT [J].
Roth, WK ;
Seifried, E .
TRANSFUSION MEDICINE, 2002, 12 (04) :255-258
[7]  
Roth WK, 2000, VOX SANG, V78, P257
[8]   USNAT yield: where are we after 2 years? [J].
Stramer, SL .
TRANSFUSION MEDICINE, 2002, 12 (04) :243-253
[9]   Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins [J].
Thomas, I ;
Di Giambattista, M ;
Gérard, C ;
Mathys, E ;
Hougardy, V ;
Latour, B ;
Branckaert, T ;
Laub, R .
VOX SANGUINIS, 2003, 84 (04) :300-307